We are live on
!
Find out more
RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$810M
1-Year Est. Return
30.2%
This Fund
S&P 500
1 Year Est. Return
+30.2%
AUM
$810M
AUM Growth
-$260M
(-24%)
Holding
105
Top Buys
| 1 | +$17.2M | |
| 2 | +$16.8M | |
| 3 | +$15.5M | |
| 4 |
Abbott
ABT
|
+$12.6M |
| 5 |
WAY
Waystar Holding Corp
WAY
|
+$9.09M |
Top Sells
| 1 | +$22M | |
| 2 | +$21.3M | |
| 3 | +$19.7M | |
| 4 |
Danaher
DHR
|
+$17.2M |
| 5 |
Align Technology
ALGN
|
+$16M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Boston Scientific
BSX
$72.4B
| $39.2M | 4.84% |
625,000
+193,793
|
|
||
2
Regeneron Pharmaceuticals
REGN
$64.1B
| $37.2M | 4.59% |
48,100
-13,300
|
|
||
3
Eli Lilly
LLY
$1.02T
| $31M | 3.83% |
33,715
-8,505
|
|
||
4
Insmed
INSM
$20.4B
| $26.1M | 3.22% |
159,760
+46,175
|
|
||
5
CVS Health
CVS
$124B
| $24.2M | 2.98% |
336,500
+1,000
|
|
||
6
Gilead Sciences
GILD
$159B
| $23.4M | 2.88% |
167,750
+41,600
|
|
||
7
Thermo Fisher Scientific
TMO
$175B
| $20.3M | 2.51% |
41,340
+7,700
|
|
||
8
Biogen
BIIB
$28.4B
| $20M | 2.47% |
109,100
+16,750
|
|
||
9
Vertex Pharmaceuticals
VRTX
$112B
| $19.4M | 2.4% |
43,485
+9,230
|
|
||
10
Alignment Healthcare
ALHC
$3.17B
| $18.6M | 2.29% |
1,053,450
+44,000
|
|
||
11
Intuitive Surgical
ISRG
$148B
| $17M | 2.1% |
36,846
-11,154
|
|
||
12
Cencora
COR
$53.3B
| $16.5M | 2.03% |
52,375
-11,000
|
|
||
13
Stryker
SYK
$116B
| $15.7M | 1.94% |
+47,800
|
|
||
14
AbbVie
ABBV
$394B
| $15.6M | 1.92% |
71,575
-39,000
|
|
||
15
Veeva Systems
VEEV
$27.3B
| $15M | 1.85% |
+85,300
|
|
||
16
McKesson
MCK
$92.2B
| $14.6M | 1.8% |
16,850
-8,750
|
|
||
17
Jazz Pharmaceuticals
JAZZ
$14.6B
| $14.3M | 1.77% |
75,890
+1,860
|
|
||
18
Guardant Health
GH
$16.6B
| $13.4M | 1.65% |
145,000
+65,000
|
|
||
19
Neurocrine Biosciences
NBIX
$16.4B
| $13.3M | 1.64% |
100,841
-24,650
|
|
||
20
Edwards Lifesciences
EW
$49.4B
| $13.1M | 1.61% |
163,000
-30,500
|
|
||
21
Madrigal Pharmaceuticals
MDGL
$10.8B
| $12.6M | 1.55% |
24,050
+4,500
|
|
||
22
UnitedHealth
UNH
$369B
| $12.3M | 1.52% |
45,500
-9,400
|
|
||
23
Procept Biorobotics
PRCT
$1.61B
| $11.9M | 1.47% |
475,000
-136,000
|
|
||
24
BioMarin Pharmaceuticals
BMRN
$10.9B
| $11.7M | 1.44% |
207,000
-8,000
|
|
||
|
25
Abbott
ABT
$158B
| $11.5M | 1.42% |
+112,000
|
|